-
Related Articles Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation.
J Pharmacol Sci. 2016 Jun;131(2):84-92
Authors: Park J, Yeom M, Hahm DH
Abstract
Hyperlipidemia is associated with increased risk of the development of cardiovascular diseases. Although a great deal of attention has been paid to the hypolipidemic activity of fucoidan, complex polysaccharides from Lees meerSource:: Pubmed